HomeZYDUSWELL › Filing
🔔 Get instant alerts when ZYDUSWELL files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 04 Aug 2026, 12:27 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY27 net sales 14,299 mn +66.7% y-y; EBITDA 2,417 mn +55.3%; PAT 1,189 mn -7.0% - Core business and Comfort Click drove EBITDA margin expansion to 16.8% - Sugar Free Green grew double digits for 21st consecutive quarter; strong digital campaigns - International business delivered high double-digit growth; expanded Gulf and US presence - New product launches include Complan Power Play Milkshake and VieMax Diabetes Care - Organized domestic channel saliency rose to 38% with strong e-commerce growth - Gross margin improved to 65.5% supported by Comfort Click acquisition - Board strengthened with new Independent Director Apurva S. Diwanji from May 2026
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ZYDUSWELL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ZYDUSWELL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Zydus Wellness Limited

Important. The summary above is generated automatically from Zydus Wellness Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.